Description: Jamjoom Pharmaceuticals Factory Company manufactures and markets pharmaceutical products in the Kingdom of Saudi Arabia and internationally. The company offers products human medicines, nutraceuticals, antibiotics, general analgesics, medicines for treatment of cough, allergy, asthma, heart diseases, blood pressure, diarrhea, vomiting, ulcer, and acidity, as well as various skin infections, cancer diseases, eye drops and ointments, and cosmeceuticals. Jamjoom Pharmaceuticals Factory Company was founded in 1994 and is based in Jeddah, the Kingdom of Saudi Arabia.
Home Page: www.jamjoompharma.com
Corniche Road
Jeddah,
21442
Saudi Arabia
Phone:
966 12 608 1111
Officers
| Name | Title |
|---|---|
| Mr. Tarek Youssef Hussein Hosni | Chief Executive Officer |
| Mr. Ahmed Yousuf Mohammed Salah Jamjoom | Vice Chairman |
| Mr. Anwer Muhiuddin | Chief Financial Officer |
| Mr. Mohammed Mahmoud Jamjoom | Head of Business Operations & Operations Director |
| Hussam Salousa | Head of Business Development & Strategy and IR Director |
| Mr. Ammar Abdulrahman Al Attas | Head of the Legal Department & Group Legal Director |
| Mr. Mohammed Ahmed Batarfi | Human Resources Director |
| Mr. Idrees Ahmed Siddiqui | Head of Manufacturing Operations |
| Mr. Faisal Ahmed Ibrahim Linjawi | Board Secretary |
Exchange: SR
Country: SA : Saudi Arabia
Currency: Saudi riyal (SR)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 31.4629 |
| Price-to-Book MRQ: | 7.6075 |
| Price-to-Sales TTM: | 8.669 |
| IPO Date: | 2023-06-01 |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |